General Information of the Compound
Compound ID |
CP0659028
|
||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Compound Name |
(6E,8Z,11Z,14Z)-5-oxoicosa-6,8,11,14-tetraenoic acid
Show/Hide
|
||||||||||||||||||
Synonyms |
[3H]-5-oxo-ETE
(6E,8Z,11Z,14Z)-5-Oxoicosa-6,8,11,14-tetraenoic acid
106154-18-1
5-Kete
5-Keto-6,8,11,14-eicosatetraenoic acid
5-Oxo-ETE
5-Oxo-eicosatetraenoate
5-Oxoeicosatetraenoic acid
5-Oxoete
5-Oxoicosatetraenoic acid
5-keto-ETE
5-ketoeicosatetraenoic acid
5-oxo-6E,8Z,11Z,14Z-eicosatetraenoic acid
5-oxo-ETE
AC1NR1NN
BML1-D12
BSPBio_001453
CHEBI:52449
CHEMBL18028
ETE-5-Oxo
GTPL3391
GTPL3416
HMS1361I15
HMS1791I15
HMS1989I15
HMS3402I15
LMFA03060011
MEASLHGILYBXFO-XTDASVJISA-N
SCHEMBL139762
ZINC4655377
[3H]-5-oxo-ETE
[3H]5-oxo-ETE
Show/Hide
|
||||||||||||||||||
Structure |
|
||||||||||||||||||
Formula |
C20H30O3
|
||||||||||||||||||
Molecular Weight |
318.457
|
||||||||||||||||||
Canonical SMILES |
CCCCC/C=C\C/C=C\C/C=C\C=C\C(=O)CCCC(=O)O
Show/Hide
|
||||||||||||||||||
InChI |
InChI=1S/C20H30O3/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-16-19(21)17-15-18-20(22)23/h6-7,9-10,12-14,16H,2-5,8,11,15,17-18H2,1H3,(H,22,23)/b7-6-,10-9-,13-12-,16-14+
Show/Hide
|
||||||||||||||||||
InChIKey |
MEASLHGILYBXFO-XTDASVJISA-N
|
||||||||||||||||||
Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
PubChem ID | |||||||||||||||||||
ChEMBL ID |
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
---|
Table of Molecular Bioactivities Related to the Compound
Clinical Information about the Compound
Drug 1 ( [3H]5-oxo-ETE )
Drug Name | [3H]5-oxo-ETE | ||
---|---|---|---|
Target(s) |
Oxoeicosanoid receptor 1 (OXER1)
Agonist
|